Top Markets
Coin of the day
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
Classement en actions #33557
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
Prix de l'action
$0.11989842
Capitalisation boursière
$7.42M
Changement (1 jour)
6.25%
Changement (1 an)
179.27%
Pays
AU
Échange Vectus Biosystems Limited (VBS)

Catégorie

Historique des divisions d’actions pour Vectus Biosystems Limited (VBS)
L’action Vectus Biosystems Limited (symbole : VBS) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 17, 2026.
Une action VBS achetée avant le Aug 17, 2026 équivaudrait aujourd’hui à 0 actions VBS.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE